The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The Influence of Cholestyramine on Thyroxine Absorption
Abstract
Cholestyramine resin, an anionic exchange resin, currently being investigated as an agent for lowering serum cholesterol levels, has been shown to interfere with the absorption of ingested thyroid hormone. A small quantity of the resin is capable of binding thyroxine under the conditions encountered in the gastrointestinal tract. Interference with thyroid hormone absorption by cholestyramine can be minimized by allowing a time interval of at least four hours between the ingestion of the two agents. Hypothyroid patients receiving cholestyramine should be examined periodically for evidence of hypothyroidism, and adjustments in dose and time interval between the two agents should be made if malabsorption of thyroid hormone is significant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The list of medications that can alter the absorption of LT4 is extensive and includes calcium carbonate (132-134), PPIs (135), bile acid sequestrants (cholestyramine and colesevelam) (136,137), phosphate binders (138,139), ferrous sulfate (140,141), aluminum-containing antacids (142,143), and sucralfate (144,145).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [136]
In the citing paper
“Both of these reports incorporated pharmacokinetic studies in healthy volunteers showing reduced absorption with co-administration of the agent and LT4.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [136]
In the citing paper
“Two studies have implicated bile acid sequestrants as being responsible for binding LT4 within the intestine (136,137).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [136]
In the citing paper
“It is widely acknowledged that direct complexation and chelation play important roles in the malabsorption of LT4 induced by the intake of many drugs, including calcium and iron supplements (72, 73), aluminum-containing antacids (74), bile acid sequestrants (75, 76), and some foods (eg, fiber-rich foods, coffee, and milk) (22, 77, 78).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [75]
Citations
Cites
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
In Vitro Method for the Study of the Rate of Intestinal Absorption of Sugars
Crane, R. K., & Wilson, T. H. (1958) · Journal of Applied Physiology · doi:10.1152/jappl.1958.12.1.145 · Cited by 173
Effect of an Anion Exchange Resin on Serum Cholesterol in Man.
Bergen, S. S., Itallie, T. B. V., Tennent, D. M., & Sebrell, W. H. (1959) · Experimental Biology and Medicine · doi:10.3181/00379727-102-25358 · Cited by 101
The Interaction Between Cholestyramine and Drugs
Gallo, D. G., Bailey, K. R., & Sheffner, A. L. (1965) · Experimental Biology and Medicine · doi:10.3181/00379727-120-30443 · Cited by 88
Moore, R. B., Crane, C. A., & Frantz, I. D. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105857 · Cited by 76
Response of Hyperlipoproteinemia to Cholestyramine Resin
Fallon, H. J. (1968) · JAMA · doi:10.1001/jama.1968.03140260001001 · Cited by 51
INFLUENCE OF CHOLESTYRAMINE ON ABSORPTION AND EXCRETION OF THYROXINE IN SYRIAN HAMSTER
Bergman, F., Heedman, P., & LINDEN, W. V. D. (1966) · European Journal of Endocrinology · doi:10.1530/acta.0.0530256 · Cited by 25
Enterohepatic circulation of thyroxine in humans.
Myant, N. B. (1956) · PubMed · Cited by 25
Johnson, P. C., & Beierwaltes, W. H. (1953) · PubMed · Cited by 11
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“Two studies have implicated bile acid sequestrants as being responsible for binding LT4 within the intestine (136,137).”
Satoh, T., Isozaki, O., Suzuki, A., Wakino, S., Iburi, T., Tsuboi, K., Kanamoto, N., Otani, H., Furukawa, Y., Teramukai, S., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0336 · Cited by 262
Conditions and drugs interfering with thyroxine absorption
Liwanpo, L., & Hershman, J. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.006 · Cited by 222
Effect of calcium carbonate on the absorption of levothyroxine
Singh, N. (2000) · JAMA · doi:10.1001/jama.283.21.2822 · Cited by 219
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
Levy, R. I., FREDRICKSON, D. S., SHULMAN, R., BILHEIMER, D. W., Breslow, J. L., STONE, N. J., LUX, S. E., SLOAN, H. R., Krauss, R. M., & HERBERT, P. N. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-2-267 · Cited by 183
A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism
Colucci, P., Yue, C. S., Ducharme, M., Benvenga, S., Principal Scientist, L. A. C. I., Principal Scientist, L. A. C. I. A. P. C., President and CEO, L. A. C. I., & Professor of Medicine, D. (2010) · European Endocrinology · doi:10.17925/ee.2013.09.01.40 · Cited by 167
Interactions Affecting Drug Absorption
Welling, P. G. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409050-00002 · Cited by 166
Gastrointestinal malabsorption of thyroxine
Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00168 · Cited by 164
Imatinib induces hypothyroidism in patients receiving levothyroxine
DEGROOT, J., ZONNENBERG, B., PLUKKER, J., VANDERGRAAF, W., & LINKS, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.010 · Cited by 159
Hypothyroidism in the Elderly*
ROBUSCHI, G., Safran, M., Braverman, L. E., GNUDI, A., & Roti, E. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-142 · Cited by 140
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review
Skelin, M., Lucijanić, T., Amidžić Klarić, D., Rešić, A., Bakula, M., Liberati-Čizmek, A.-M., Gharib, H., & Rahelić, D. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.005 · Cited by 133
Interruption of the enterohepatic circulation of digitoxin by cholestyramine
Caldwell, J. H., & Greenberger, N. J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106763 · Cited by 123
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 142
The Use and Misuse of Thyroid Hormone*
Roti, E., Minelli, R., Gardini, E., & Braverman, L. E. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-401 · Cited by 106
Sucralfate causes malabsorption of L-thyroxine
Sherman, S. I., Tielens, E. T., & Ladenson, P. W. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90093-0 · Cited by 105
Pseudomalabsorption of levothyroxine
Ain, K. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470150090036 · Cited by 100
Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide
Liel, Y., Sperber, A. D., & Shany, S. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90303-4 · Cited by 83
Tsai, W., Pei, D., Wang, T., Wu, D., Li, J., Wei, C. L., Lee, C., Chen, S., & Kuo, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02249.x · Cited by 83
Adjunctive cholestyramine therapy for thyrotoxicosis*
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00970.x · Cited by 83
New medications which decrease levothyroxine absorption
John-Kalarickal, J., Pearlman, G., & Carlson, H. E. (2007) · Thyroid · doi:10.1089/thy.2007.0060 · Cited by 82
Drug treatment of hyperlipidemia
Yeshurun, D., & Gotto, A. M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90755-5 · Cited by 79
The Acute Effect of Calcium Carbonate on the Intestinal Absorption of Levothyroxine
Singh, N., Weisler, S. L., & Hershman, J. M. (2001) · Thyroid · doi:10.1089/105072501753211046 · Cited by 77
Absorption of Levothyroxine When Coadministered with Various Calcium Formulations
Zamfirescu, I., & Carlson, H. E. (2011) · Thyroid · doi:10.1089/thy.2010.0296 · Cited by 76
Raloxifene Causing Malabsorption of Levothyroxine
Siraj, E. S., Gupta, M. K., & Reddy, S. S. K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1367 · Cited by 76
Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia
Glueck, C. J. (1972) · JAMA · doi:10.1001/jama.222.6.676 · Cited by 75
Effects of grapefruit juice on the absorption of levothyroxine
Lilja, J. J., Laitinen, K., & Neuvonen, P. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02433.x · Cited by 74
Pirola, I., Formenti, A. M., Gandossi, E., Mittempergher, F., Casella, C., Agosti, B., & Cappelli, C. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1015-y · Cited by 74
Adverse Effects of Hypolipidaemic Drugs
Knodel, L. C., & Talbert, R. L. (1987) · Medical Toxicology · doi:10.1007/bf03259858 · Cited by 71
Gut-thyroid interrelationships
Miller, L. J., Gorman, C. A., & Go, V. L. W. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90478-x · Cited by 69
Treatment of hyperthyroidism with a combination of methimazole and cholestyramine
Mercado, M., Mendoza‐Zubieta, V., Bautista-Osorio, R., & Monteros, A. L. E. D. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784067 · Cited by 67
Sperber, A. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400130181024 · Cited by 66
Levothyroxine: conventional and novel drug delivery formulations.
Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac030 · Cited by 63
Serum Thyrotropin Levels Following Levothyroxine Administration at Breakfast
Perez, C. L. S., Araki, F. S., Graf, H., & de Carvalho, G. A. (2013) · Thyroid · doi:10.1089/thy.2012.0435 · Cited by 63
Rubio, I. G. S., Galrão, A. L., Santo, M. A., Zanini, A. C., & Medeiros-Neto, G. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0452-8 · Cited by 58
Low doses of cholestyramine in the treatment of hyperthyroidism
Kaykhaei, M. A., Shams, M., Sadegholvad, A., Dabbaghmanesh, M. H., & Omrani, G. R. (2008) · Endocrine · doi:10.1007/s12020-008-9107-5 · Cited by 58
Caron, P., Grunenwald, S., Persani, L., Borson-Chazot, F., Leroy, R., & Duntas, L. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09691-9 · Cited by 53
Preparation for radioactive iodine administration in differentiated thyroid cancer patients
Liel, Y. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01631.x · Cited by 53
Cayen, M. N. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90028-2 · Cited by 48
Levothyroxine-Cholestyramine Interaction Reemphasized
Harmon, S. M., & Seifert, C. F. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-658_2 · Cited by 48
Mersebach, H., Rasmussen, Å. K., Kirkegaard, L., & Feldt‐Rasmussen, U. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb00883.x · Cited by 45
Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid
Thomas, G. A., & Williams, E. D. (1991) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(91)90068-y · Cited by 44
Levothyroxine Binding by Sucralfate
Havránková, J., & Lahaie, R. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-445_3 · Cited by 41
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
de Carvalho, G. A., Paz-Filho, G., Mesa, C. O., & Graf, H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0947 · Cited by 41
Choosing the Right Lipid-Regulating Agent
Farmer, J. A., & Gotto, A. M. (1996) · Drugs · doi:10.2165/00003495-199652050-00003 · Cited by 40
Farmer, J. A., & Gotto, A. M. (1994) · Drug Safety · doi:10.2165/00002018-199411050-00002 · Cited by 39
A Comparative Review of the Adverse Effects of Treatments for Hyperlipidaemia
Steiner, A., Weisser, B., & Vetter, W. (1991) · Drug Safety · doi:10.2165/00002018-199106020-00003 · Cited by 39
The Effect of Famotidine, Esomeprazole, and Ezetimibe on Levothyroxine Absorption
Ananthakrishnan, S., Braverman, L. E., Levin, R. M., Magnani, B., & Pearce, E. N. (2008) · Thyroid · doi:10.1089/thy.2007.0381 · Cited by 38
Effects of the Environment, Chemicals and Drugs on Thyroid Function
Sarne, D. (2016) · Cited by 38
Longstreth, G. F., & Newcomer, A. D. (1975) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)09668-5 · Cited by 37
Drug Interference in Clinical Biochemistry
Sunderman, F. W., & Derman, H. (1970) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408367009027950 · Cited by 36
Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine
Weitzman, S. P., Ginsburg, K. C., & Carlson, H. E. (2009) · Thyroid · doi:10.1089/thy.2008.0312 · Cited by 35
Enhancement of Xenobiotic Elimination: Role of Intestinal Excretion
Israili, Z. H., & Dayton, P. G. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409033559 · Cited by 35
POLEY, J. R., Alaupovic, P., Wj, M., Seidel, D., ROY, C. C., & Weber, A. M. (1973) · PubMed · Cited by 35
Concurrent milk ingestion decreases absorption of levothyroxine
Chon, D. A., Reisman, T., Weinreb, J. E., Hershman, J. M., & Leung, A. M. (2018) · Thyroid · doi:10.1089/thy.2017.0428 · Cited by 34
Lipoprotein-X and the double 131I-rose bengal test in the diagnosis of prolonged infantile jaundice
Poley, J. R., Smith, E. I., Boon, D. J., Bhatia, M., Smith, C. W., & Thompson, J. (1972) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(72)90276-x · Cited by 34
Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future
Suwansaksri, N., Preechasuk, L., & Kunavisarut, T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5794054 · Cited by 35
Sebastián-Ochoa, A., Quesada‐Charneco, M., Fernández‐García, D., Reyes‐García, R., Rozas-Moreno, P., & Escobar‐Jiménez, F. (2008) · Thyroid · doi:10.1089/thy.2008.0094 · Cited by 31
Clinical Pharmacokinetics of Hypolipidaemic Drugs
Gugler, R. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803060-00001 · Cited by 31
Currently available hypolipidaemic drugs and future therapeutic developments.
Farmer, J. A., & Gotto, A. (1995) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80177-4 · Cited by 35
Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review
Liu, H., Lu, M., Hu, J., Fu, G., Feng, Q., Sun, S., & Chen, C. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s414460 · Cited by 29
In Vitro Binding of Drugs to Colestipol Hydrochloride
Ko, H., & Royer, M. E. (1974) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600631218 · Cited by 26
He, L., Wickremasingha, P., Lee, J., Tao, B., Mendell-Harary, J., Walker, J., & Wight, D. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.033 · Cited by 25
Thyroid Hormone and Thyrotropin Levels in Patients Placed on Colestipol Hydrochloride*
Witztum, J. L., JACOBS, L. S., & Schonfeld, G. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-5-838 · Cited by 25
Yang, Y., Hwang, S., Kim, M., Lim, Y., Kim, M.-H., Lee, S., Lim, D.-J., Kang, M.-I., & Cha, B.-Y. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.4.620 · Cited by 24
BROWN, M. E., & Refetoff, S. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-491 · Cited by 24
Metabolic Disposition of Antihyperlipidemic Agents in Man and Laboratory Animals
Cayen, M. N. (1980) · Drug Metabolism Reviews · doi:10.3109/03602538008994028 · Cited by 24
Apparent Reduced Absorption of Gemfibrozil When Given with Colestipol
Forland, S. C., Feng, Y., & Cutler, R. E. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03434.x · Cited by 24
Inhibition of the intestinal absorption of inorganic and hemoglobin iron by cholestyramine.
Thomas, F. B., McCullough, F. S., & Greenberger, N. J. (1971) · PubMed · Cited by 24
Clinical Relevancy of the Levothyroxine–Continuous Enteral Nutrition Interaction
Dickerson, R. N., Maish, G. O., Minard, G., & Brown, R. O. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610385701 · Cited by 23
Cation-exchange resin and inhibition of intestinal absorption of thyroxine
Mclean, M., Kirkwood, I., Epstein, M., Jones, B., & Hall, C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91195-r · Cited by 20
Current trends in antithyroid drug treatment of Graves’ disease
Okosieme, O. E., & Lazarus, J. H. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1232388 · Cited by 19
Sawin, C. T. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31001-x · Cited by 19
Thompson, W. G. (1971) · PubMed Central · Cited by 18
Effect of cholestyramine and colestipol on the absorption of phenytoin
Callaghan, J. T., Tsuru, M., Holtzman, J. L., & Hunninghake, D. B. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542221 · Cited by 17
Role of colestipol in the treatment of hyperthyroidism
Hagag, P., Nissenbaum, H., & Weiss, M. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03348036 · Cited by 16
Interference with the absorption of levothyroxine
Singh, N. K., & Hershman, J. M. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200310000-00008 · Cited by 15
Alterations in Serum Thyroid Hormonal Indices with Colestipol-Niacin Therapy
Cashin-Hemphill, L., SPENCER, C. A., NICOLOFF, J. T., BLANKENHORN, D. H., NESSIM, S. A., CHIN, H. P., & LEE, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-324 · Cited by 15
Pharmacological treatment of lipid disorders in diabetes mellitus
Lopes-Virella, M. F., & Colwell, J. A. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030305 · Cited by 15
Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting
Rdzak, G. M., Whitman, L. M., & Inzucchi, S. E. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818771433 · Cited by 14
ILEAL BYPASS IN THE TREATMENT OF HYPERLIPOPROTEINÆMIA
Thompson, G., & Gotto, A. M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91962-4 · Cited by 14
Clinically Relevant Drug-Drug and Drug-Food Interactions
Brewer, L., & Williams, D. J. (2013) · Pharmaceutical Medicine · doi:10.1007/s40290-013-0008-4 · Cited by 13
Phosphate binders and timing of levothyroxine administration
Árnadóttir, M., & Johannesson, A. J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm615 · Cited by 13
Review of Heterotopic Thyroid Autotransplantation
Sakr, M. F., & Mahmoud, A. (2017) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2016.01578 · Cited by 14
Pharmaceutical Sciences—1968. A Literature Review of Pharmaceutics
Bernardo, P. D., & Russo, E. J. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580702 · Cited by 13
Non-thionamide antithyroid drug options in Graves’ hyperthyroidism
Ruslan, A. M., & Okosieme, O. E. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2167709 · Cited by 13
Drug-Cholestyramine Interactions II: Influence of Cholestyramine on GI Absorption of Sodium Fusidate
Johns, W. H., & Bates, T. R. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610513 · Cited by 11
A Case of Refractory Hypothyroidism Requiring Daily Intravenous Thyroxine
Nagaoka, T., Miyakoshi, H., Takamura, T., Nagai, Y., Matsushita, S., Kaneko, S., & KOBAYASHI, K. P. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000418 · Cited by 11
Nicotinic Acid Decreases Serum Thyroid Hormone Levels While Maintaining a Euthyroid State
Shakir, K. M. M., Kroll, S., Aprill, B. S., Drake, A. J., & Eisold, J. F. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.6.556 · Cited by 11
Refetoff, S. (1975) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31964-2 · Cited by 11
Sato, K., Emoto, N., TORAYA, S., Tsushima, T., Demura, H., Tsuji, N., Inaba, S., Takeuchi, A., & Kobayashi, T. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.329 · Cited by 10
Intestinal Absorption of Xenobiotics
Csáky, T. Z. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69508-7_1 · Cited by 10
Heim, M., Nixon, I. J., Emmerson, E., & Callanan, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.997288 · Cited by 12
Vagenakis, A. G., & Braverman, L. E. (1976) · Pharmacology & Therapeutics Part C Clinical Pharmacology and Therapeutics · doi:10.1016/s0362-5486(76)80011-8 · Cited by 9
The Use of Konjac Glucomannan to Lower Serum Thyroid Hormones in Hyperthyroidism
Azezli, A., Bayraktaroğlu, T., & Orhan, Y. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719645 · Cited by 8
Weiss, R. E., & Refetoff, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00078-0 · Cited by 8
Nies, A. S. (1974) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32093-4 · Cited by 8
Probable interaction of loperamide and cholestyramine.
Ti, T. Y., Giles, H. G., & Sellers, E. M. (1978) · PubMed Central · Cited by 7
Drug Interactions in Clinical Medicine
Rosenoer, V. M., & Gill, G. M. (1972) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32372-0 · Cited by 7
Johns, W. H., & Bates, T. R. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610512 · Cited by 6
Metadata
- Authors
- Northcutt, R. C.
- Corresponding author
- Northcutt, Robert C.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1969-06-09
- Volume
- 208
- Issue
- 10
- Pages
- 1857
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1998922937
- Cited by
- 144
- References
- 9
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- cholestyramine, anion exchange resin, hypothyroidism, drug interactions, serum cholesterol lowering, timing of drug administration
- MeSH terms
- Animals, Anticholesteremic Agents, Cholestyramine Resin, Female, Humans, Intestinal Absorption, Iodine, Iodine Isotopes, Ion Exchange Resins, Thyroid Hormones, Thyroxine, Time Factors, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
